{
    "nctId": "NCT05779982",
    "briefTitle": "SURPASS Retrospective Study",
    "officialTitle": "Outcomes of Sentinel Node Biopsy According to MRI Response in an Association With the Subtypes in cN1-3 Breast Cancer After Neoadjuvant Systemic Therapy",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Breast MRI, Neoadjuvant Systemic Therapy, Sentinel Lymph Node",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 500,
    "primaryOutcomeMeasure": "False negative rate of sentinel lymph node biopsy according to radiologic response stratified by brest cancer subtype",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* cN1-3 breast cancer at initial presentation\n* received neoadjuvant systemic therapy (NAST)\n* received sentinel lymph node biopsy (SLNB) followed by additional axillary lymph node dissection (ALND)\n* breast MRI performed at baseline and post-NAST.\n\nExclusion Criteria:\n\n* case with unavailable data for breast MRI and operation",
    "sex": "FEMALE",
    "minimumAge": "19 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}